Roeker, L. E., Woyach, J. A., Cheah, C. Y. Y., Coombs, C. C., Shah, N. N., Wierda, W. G., Patel, M. R., Lamanna, N., Tsai, D. E., Nair, B. C., Wang, C., Zhao, X., Liu, D., Radtke, D., Chapman, S., Marella, N., McNeely, S. C., & Brown, J. R. (2024). Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood Journal. https://doi.org/10.1182/blood.2024024510